12 Tips for Drafting Health, Bio, and Pharma Press Releases
Press releases in the health and life sciences sector carry high stakes. Whether announcing a regulatory approval, pivotal trial data, or a new therapeutic innovation, your message must meet rigorous standards for accuracy, clarity, and compliance.
Discover best practices for crafting high-impact press releases tailored for the healthcar e ecosystem. From targeting segmented audiences to aligning with compliance and SEO, here are twelve key strategies that every communicator in health, bio, or pharma should master.
Tips to Write High Impact Press Releases:
Know and segment your audiences
Craft a precise, compliant headline and subheadline
Write a data-rich lead paragraph
Present scientific results clearly
Ensure regulatory and ethical compliance
Include patient-centric summaries
Leverage experts
Utilize multimedia for life sciences
Apply SEO and metadata best practices
Fine-tune your distribution strategy
Timing and coordination
Post-distribution monitoring and engagement
1. Know and Segment Your Audiences
Not all readers of a healthcare press release are the same, and neither is the language they expect. Your press release should clearly distinguish between its core audience groups and meet their unique informational needs.
Healthcare Professionals require a clinical, evidence-based tone. For example, include detailed trial data, explain how the treatment works, and highlight how it fits into existing treatment guidelines.
Patients and Caregivers need empathetic communication in plain language. Provide simplified summaries, a clear description of the side effect profile, and links to support services or hotlines.
Investors and Analysts are looking for strategic insights and commercial potential. Focus on market opportunity, patent coverage, and financial outlook. Invite them to review an investor deck or attend an analyst call.
Regulators and Ethics Committees expect formal, compliance-driven language. Include institutional review board approval details, safety monitoring procedures, and any reporting requirements to ensure transparency.
Effective segmentation ensures each audience can act on what matters most to them without confusion or jargon overload.
2. Craft a Precise, Compliant Headline and Subheadline
Don't underestimate the impact of a clear, standards-based headline. A compelling headline grabs attention and concisely delivers key information. Aim for under 250 characters and include the drug or technology name and what it treats.
Follow this with a brief subheadline that expands on your headline and provides additional context.
3. Write a Data-Rich Lead Paragraph
The lead paragraph of a health-sector press release must answer the critical '5 W's' quickly: What happened, who conducted the study, when and where it took place, and why it matters.
State the primary result plainly. For example, 'In a randomized trial, ABC-123 demonstrated a 45 percent reduction in flare-ups versus placebo.' Include the trial ID (e.g., NCT01234567) and link to full data if available. This section should set the stage for deeper detail to follow.
4. Present Scientific Results Clearly
When describing data, clarity and structure matter. Even experienced clinicians appreciate well-organized information.
Study Design: Be clear about how the study was set up – mention things like randomization, control groups, and whether it was blinded.
Endpoints and Metrics: Highlight the main goals of the study and any secondary ones, too. Include details like how many people were in the trial, plus p-values, hazard ratios, and confidence intervals.
Safety Profile: Give a quick summary of any side effects, especially serious ones, and note how often participants stopped the treatment because of them.
Data Access: Link directly to ClinicalTrials.gov, a peer-reviewed publication, or a supplementary data PDF. This enhances transparency and builds trust.
By laying out the methodology and findings succinctly, your press release becomes a trusted resource for all stakeholders.
5. Ensure Regulatory and Ethical Compliance
In pharma and biotech communications, compliance is not optional. Your press release must address ethical and legal standards head-on.
Always include mandatory disclaimers, such as those related to forward-looking statements or off-label use. Mention the IRB or ethics committee that approved the study and provide the protocol number. Make clear that informed consent was obtained per GCP (Good Clinical Practice). Provide details on how adverse events can be reported, such as a link to the FDA MedWatch site.
These additions demonstrate due diligence and protect your organization from scrutiny or legal consequences.
6. Include Patient-Centric Summaries
While scientific accuracy is essential, the human element should never be lost. These elements remind readers that behind every statistic is a person and, often, a breakthrough.
Include a quote from a patient or caregiver who participated in the study (with their permission). These real-world voices bring a human voice to the data, making your story more relatable, memorable, and emotionally impactful.
Highlight the real-world impact: how the therapy improves daily life, reduces hospital visits, or enables independence. And link to supporting organizations or educational materials that offer more context for those affected.
7. Leverage Experts
A strong quote from a lead researcher can clarify the study's importance and hint at future directions.
Where possible, include commentary from an independent KOL (Key Opinion Leader) to validate findings in a broader scientific context.
Be sure to include each expert's credentials and affiliations to bolster credibility: full name, degrees, and institutional role. This not only humanizes your announcement but also boosts its authority and likelihood of media pickup.
8. Utilize Multimedia for Life Sciences
Visual content makes complex medical stories easier to understand—and easier to share. Consider:
High-quality clinical graphs like Kaplan-Meier curves or subgroup forest plots.
Infographics that illustrate how a treatment works or show a patient's journey.
An animated video abstract showing drug interactions at the molecular level.
High-resolution photography showing lab work, devices, or packaging.
9. Apply SEO and Metadata Best Practices
Health-sector press releases benefit significantly from optimized metadata and search visibility. Start by researching keywords using MeSH terms and layperson synonyms (e.g., 'myocardial infarction' and 'heart attack').
Add relevant keywords to your headline, subheadline, and first paragraph to boost discoverability. Keep your format clear and easy to scan by using bulleted lists. Make the most of Business Wire's free press release features – Release Summary and Callout Text. These features are ideal for highlighting key points of your news, plus they work as attractive snippets for both AI and search engine results.
All multimedia should include descriptive captions. Add both internal links (to your corporate site or product page) and external references (e.g. peer-reviewed studies) to strengthen SEO authority.
10. Fine-Tune Your Distribution Strategy
Having a targeted distribution strategy is essential when sharing health, pharmaceutical, or biotech news. Precision matters – not just in the message itself, but in how and where that message is delivered.
Partnering with a trusted newswire like Business Wire ensures your press release reaches the right audiences through the right channels. Business Wire offers advanced targeting capabilities to distribute news by geography, industry, and demographic, maximizing the relevance and impact of your announcement.
For companies in the health and life sciences space, Business Wire's HealthWire circuit is especially valuable. HealthWire is designed to connect your news with healthcare reporters, analysts, local media outlets, and trade publications, while also extending your reach to key internet portals and databases.
To truly amplify the reach and effectiveness of your announcement, it's best practice to share your news across additional channels.
Use paid media, such as promoted LinkedIn posts or sponsored content on medical news sites, to boost visibility among target stakeholders.
Share your press release and related content across your company's social media channels to encourage engagement and expand organic reach.
Leverage your owned media – your website, blog, or newsletter – to provide deeper context and a permanent home for your announcement.
By combining the power of a targeted newswire with a comprehensive outreach strategy, you can ensure your health-related news reaches the right audiences and drives meaningful impact.
11. Timing and Coordination
For the biggest impact, try to time your press release to go out when a journal article is published or during a major medical conference. Make sure to coordinate ahead of time with your medical, legal, and regulatory teams so everyone is aligned, and approvals don't cause delays. Staying in sync with your organization's scientific calendar helps you avoid overlap and gives your news a stronger, more unified push.
12. Post-Distribution Monitoring and Engagement
Tracking how your news performs is key to understanding its impact and improving future campaigns. Keep an eye on media pickups, engagement trends, and social media buzz. Tools like social listening can help you monitor hashtag performance, sentiment changes, and spikes in activity, so you know where your message is landing and how it resonates.
When you distribute your press release with Business Wire, you'll have access to NewsTrak, our press release performance dashboard. From media coverage and traffic sources to geographic reach and audience interaction, NewsTrak gives you a detailed look at your announcement's reach and engagement.
To stay ahead of the curve, have FAQs and background materials ready for the media. Staying responsive keeps your communications sharp and trustworthy.
Communicating in the health and life sciences space is both an opportunity and a responsibility. To recap:
When your message involves lives, every word and every step matters.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
Oil prices surge and stocks slump after Israel attack on Iran
Oil prices surged and stocks slumped on Friday morning in the immediate hours after Israel began an attack on Iran targeting nuclear sites and senior military officers. The strike stoked concern among investors about a possible wider conflict across the Middle East, which accounts for a large share of global oil production. The U.S. West Texas Intermediate futures price -- a key measure of U.S. oil prices -- surged more than 7% on Friday. Brent crude future prices, another top measure of oil prices, also climbed more than 7%. MORE: Israel strikes live updates: US provided 'exquisite' intel to Israel, source says Stocks, meanwhile, tumbled in early trading on Friday as the ultimate outcome of the Israel-Iran conflict remained unclear. The Dow Jones Industrial Average fell 575 points, or 1.3%, at the close of trading. The S&P 500 declined 0.8%, while the tech-heavy index slid 0.9%. The jump in oil prices threatens to raise the price of gasoline for U.S. drivers, since crude oil makes up the top ingredient in car fuel. Gas prices "will likely start to rise across much of the country later this evening in response to Israel's attacks on Iran, which have caused oil prices to surge," Patrick de Haan, the head of petroleum analysis at GasBuddy, said on Friday in a post on X. A typical gallon of gas could tick up between 10 and 25 cents, de Haan added. The average price of a gallon of gas currently stands at $3.13, AAA data shows. The price increase anticipated by de Haan would amount to a hike of as much as nearly 8%. "For now, I expect the rise to be noticeable, but limited," de Haan said. "This could change." Israel launched dozens of strikes against Iran early Friday morning local time, striking at the heart of the country's nuclear program, killing several nuclear scientists as well as high-ranking military leaders, according to Israeli officials. MORE: Trump tells ABC Israel strikes on Iran 'excellent' and warns 'more to come' Iran responded with an aerial attack involving about 100 drones, Israel said, but all of them were shot down before hitting their target. The move downward for U.S. stocks followed losses in markets across Asia and Europe. The STOXX Europe 600 index fell about 1% by late afternoon local time. In Japan, the Nikkei 225 in Tokyo dropped 0.8% on Friday. ABC News' Riley Hoffman, Leah Sarnoff, Jack Moore, Jon Haworth, and Nadine El-Bawab contributed to this report. Oil prices surge and stocks slump after Israel attack on Iran originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Boston Globe
9 hours ago
- Boston Globe
The original Cape Cod bracelet is famously hard to get. Now it's going online-only, ending a longtime tradition.
Advertisement Neighbors and customers complained. Some people figured out how to get around the ticket system. And the store couldn't keep up. Get Rhode Map A weekday briefing from veteran Rhode Island reporters, focused on the things that matter most in the Ocean State. Enter Email Sign Up So 'It was really clear we couldn't go on like this,' the owner, Rachel Carey-Harper, told the Globe. 'We're a tiny little business.' The announcement by the shop last week, which cited 'intense dislike' for the ticketing system, prompted a flurry of reaction online. Out-of-towners who have dreamed of owning an original screwball were thrilled at the prospect of buying one remotely. Advertisement But for longtime shoppers, the elusiveness was the point. Securing a ticket weeks in advance, going to Dennis, waiting in line, bringing enough cash, getting your wrist measured. It took effort. With no online catalog, Capegoers shopped each other's wrists, writing down the names of pieces so they could ask for them at the shop or in the 'onesie' line outside, where you could buy one specific piece of jewelry without even seeing it. Copycats are widely available from other jewelers, but the mystique of securing an original was part of the adventure, longtime customers said. Many people never take them off. 'Everybody who has the real Eden bracelets, you feel like a special club,' O'Toole said. She brought her 8-year-old niece to get her first screwball bracelet last summer, after waking up at 5 a.m. to stalk the website for tickets in advance. She's been going to the Cape for 15 summers, and her whole family makes a day out of her Eden trip, going to the lake across the street on the day of the reservation. Eden urges customers not to purchase the many copycats, noting that their bracelets are made in one-eighth increments to ensure a custom fit. The screwball name is trademarked, but the family tried and failed to secure a patent to stop others from copying the design, Carey-Harper said. The authentic bracelets come with a small dangling tag with an apple symbol on it. On the shop's Facebook announcement about not reopening to in-person jewelry sales, hundreds of commenters left messages with memories of visiting Dennis to buy a bracelet with their mom, their daughter, their grandmother. Advertisement 'Rather than fighting those visiting the Cape for tickets we will be fighting resellers worldwide,' one commenter said. Another celebrated, writing she'd been waiting 'years' to buy a bracelet since she lives in Michigan. It was never the owners' intention to make the bracelet so exclusive. Once a hidden gem spread by word-of-mouth, the shop was overrun after 'The Bachelorette' contestant Chris Lambton gave one of the Eden bracelets to bachelorette Ali Fedotowsky as a gift on the hit ABC franchise in 2010. 'I pleaded with him not to give it,' said Carey-Harper, whose family knew the Lambtons from Dennis. 'But he didn't listen.' Plenty of small businesses would be thrilled by the national exposure. But Carey-Harper said she almost closed the shop, one of several times it almost shuttered since it opened in the early 1960s. The store has never advertised, and Carey-Harper rarely does interviews, aiming to avoid publicity. Eden Hand Arts in Dennis, Mass., won't sell jewelry in-person at its store this year, but will offer pottery and other art. Courtesy of Eden Hand Arts She wishes it was not so popular, and cringes at the overconsumption of it all. 'The money, the exposure, the TikTok videos, I could care less about all of that,' Carey-Harper said. 'Obviously you want to make enough to pay the bills, but beyond that, how much do you need?' Carey-Harper estimates the demand compared to the supply is 'a thousand to one.' Since every bracelet is handmade by her husband and other jewelers, they would never be able to keep up — 'unless we turn it into a factory, which is not who we are.' She also didn't want to address demand by jacking up the price of a $250 bracelet to $2,000. 'I want it to be accessible,' she said. 'I don't want our art to be elitist.' Advertisement It's a 'misconception' to call Eden Hand Arts a jewelry store at all, Carey-Harper argues. The shop was started by her mother Eve Carey, a graduate of the Rhode Island School of Design, who specialized in Majolica earthenware pottery. She and her husband John, the designer of the screwball bracelet, bought the Dennis studio surrounded by a garden of apple trees in 1962 and named it Eden, a play on Eve's name. She died in 2005, and John in 2012. A brochure from 1964 details the offerings from Eve and John Carey of Eden Hand Arts in Dennis, Mass. Courtesy of Eden Hand Arts A 1964 brochure references the couples' pottery, bird paintings, glass and wire sculptures, as well as jewelry. 'Note that it doesn't mention the Cape Cod Screwball bracelet,' Carey-Harper said. Now, she hopes the 'garden,' as she calls it, will return to its roots. The store is currently closed, but will reopen in July just to sell pottery and other art, not jewelry. Repairs and exchanges for jewelry purchased in 2024 or earlier will also take place there, but not for jewelry purchased in the new online shop. Moving to online sales is a huge leap for Eden. Eve Carey didn't even use a calculator, never mind a computer, preferring to do the shop's bookkeeping by hand. The store has never accepted credit cards. Carey-Harper said she chose Etsy because an employee already knew how to run an Etsy shop. The jewelry pieces will still be handmade, so the quantity will be limited. The prices are not yet set, but she acknowledged she will need to increase them because of Etsy's cut, and also because of the rising cost of gold and silver. Also on her to-do list: recording a video instructing customers how to properly measure their wrists. Advertisement 'Life is about change,' Carey-Harper, who is 74, said in response to disappointed customers. 'Change challenges us to find the joy of new adventures. And that's what this is about. It's a new adventure.' O'Toole says the online shop 'takes away the real appeal' of buying the jewelry. 'Not everybody had a real Eden bracelet, because you had to go through all this hassle and be down the Cape.' But despite the end to her summer tradition, she said: 'I probably will buy one online. I don't think I'll be able to keep myself away.' Steph Machado can be reached at
Yahoo
11 hours ago
- Yahoo
Eric Dane remains optimistic amid ALS diagnosis: 'I don't feel like this is the end of me'
Despite his recent health struggles, Eric Dane is trying to look on the bright side. Two months after revealing he'd been diagnosed with amyotrophic lateral sclerosis, also known as ALS, the "Grey's Anatomy" alum is set to open up about his life with the rare degenerative disease in an upcoming interview with Diane Sawyer on "Good Morning America." "I wake up every day and I'm immediately reminded that this is happening," Dane, 52, tells Sawyer in a teaser clip published by the ABC talk show on June 12. Sawyer solemnly replies, "It's not a dream." ALS, commonly called Lou Gehrig's disease, is a nervous system disease that can impact the brain and spinal cord. Other stars who've battled ALS include late R&B singer Roberta Flack, world-renowned physicist Stephen Hawking, "SpongeBob SquarePants" creator Stephen Hillenburg and former U.S. Vice President Henry A. Wallace. Eric Dane reveals ALS diagnosis: What to know about the rare disease In his statement to People magazine revealing the diagnosis, Dane shared he planned on reprising his "Euphoria" role of Cal Jacobs for the HBO series' long-awaited third season. "I feel fortunate that I am able to continue working," he told the outlet. Per the National Institutes of Health, ALS progressively degrades, then kills nerve cells in the brain and spinal cord. According to one of the most recent surveys published about the disease in 2017, there were between 18,000 and 31,000 cases of ALS in the United States. The preview of Dane's interview with Sawyer, which shows the actor visibly emotional at one point, also saw Dane offer an optimistic outlook on his health ordeal. "I don't think this is the end of my story," Dane says. "I don't feel like this is the end of me." 10 bingeable memoirs to check out: Celebrities tell all about aging, marriage and Beyoncé It is not known what causes most cases of ALS, but some inherited factors have been found to cause familial ALS, which occurs when two or more people in a family have the disease. So far, a cure has not been identified for ALS. According to the ALS Society of Canada, potential early signs of the disease include tripping, dropping things, slurred or "thick" speech, difficulty swallowing, weight loss, decreased muscle tone, shortness of breath, increased or decreased reflexes and uncontrollable periods of laughing or crying. People with ALS generally live from three to five years after symptoms develop, according to the Centers for Disease Control and Prevention. How long a person lives with ALS seems to be related to age; people who are younger when the illness starts live slightly longer. Dane's "Good Morning America" interview is slated to air on Monday, June 16 at 7 a.m ET. Contributing: Natalie Neysa Alund, USA TODAY This article originally appeared on USA TODAY: Eric Dane opens up about ALS diagnosis in new interview
